Big pharma balks at investment in TB – Financial Times
Big pharma balks at investment in TBFinancial TimesMore typical was the decision by AstraZeneca in January to shut a laboratory in India where it was conducting early-stage research into TB as well as malaria and neglected tropical diseases. The UK-bas…
